Dr Griveas and Nephrology Department of 417 NIMTS published recently their experience with Covid- 19 under hemodialysis. In the following 3 links the whole publications:
- COVID-19 infection in patients receiving hemodialysis in Athens: Findings, experience, and outcome from a single Dialysis Unit
- IgM and IgG antibody response to SARS-CoV-2 Infection and Viral RNA Persistence in hospitalized chronic kidney disease patients under Hemodialysis (HD)
- Soluble urokinase plasminogen activator receptor and its complicated role in hemodialysis (HD) patients with Covid-19 infection